These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2141590)

  • 1. [A new inhalation system for bronchodilatation. Study of the acceptance of the Ingelheim M inhaler in chronic obstructive respiratory tract diseases].
    Mütterlein R; Schmidt G; Fleischer W; Freund E
    Fortschr Med; 1990 Apr; 108(11):225-8. PubMed ID: 2141590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the method of inhalation of Berodual on bronchodilation in patients over 60 years of age with diffuse bronchial obstruction].
    Czernicka-Cierpisz E; Kościńska M; Radomyski A; Sliwiński P; Zieliński J
    Pneumonol Pol; 1988 Oct; 56(10):486-91. PubMed ID: 2978275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation].
    Shmelev EI; Khmel'kova NG; Abubikirov AF
    Ter Arkh; 2000; 72(3):26-8. PubMed ID: 10776649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duovent inhaler v Inhalets in patients with asthma and chronic bronchitis.
    Town I
    N Z Med J; 1987 Nov; 100(836):726. PubMed ID: 2967935
    [No Abstract]   [Full Text] [Related]  

  • 6. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE; Archer PS; Cayton RM
    Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
    Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ
    Ann Allergy; 1988 Nov; 61(5):341-3. PubMed ID: 2973269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
    Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
    Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhalation system on trial. Current feasibility study data].
    MMW Fortschr Med; 2006 Dec; 148(49-50):53. PubMed ID: 17619332
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
    J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis].
    Iakushin SS; Smirnova EA
    Klin Med (Mosk); 1999; 77(7):49. PubMed ID: 10483167
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved inhaler confirmed in general practice. Patients with respiratory diseases can breathe freely].
    MMW Fortschr Med; 2006 Dec; 148(49-50):52. PubMed ID: 17619331
    [No Abstract]   [Full Text] [Related]  

  • 20. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
    Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
    Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.